Keyphrases
Prospective Cohort Study
100%
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
US Adults
100%
Liver-related Mortality
100%
Cardiovascular Disease
66%
Liver Disease
66%
Liver Enzymes
50%
National Health Interview Survey
33%
NHANES
33%
Adjusted Hazard Ratio
33%
Cancer Disease
33%
Enzyme Level
33%
Steatosis
33%
Non-associated
16%
Confidence Interval
16%
NHANES III
16%
Risk of Death
16%
Cause-specific Mortality
16%
Hepatic Steatosis
16%
Normal Liver
16%
Mortality from All Causes
16%
Medicine and Dentistry
Prospective Cohort Study
100%
Nonalcoholic Fatty Liver
100%
Malignant Neoplasm
66%
Cardiovascular Disease
66%
Liver Disease
66%
Liver Enzyme
50%
National Health and Nutrition Examination Survey
50%
Hazard Ratio
33%
Steatosis
33%
Prevalence
16%
Population
16%
Fatty Liver
16%
Pharmacology, Toxicology and Pharmaceutical Science
Prospective Cohort Study
100%
Nonalcoholic Fatty Liver
100%
Malignant Neoplasm
66%
Liver Disease
66%
Cardiovascular Disease
66%
Liver Enzyme
50%
Steatosis
33%
Prevalence
16%
Fatty Liver
16%